Results 191 to 200 of about 1,796 (202)

Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN)

2017
openaire   +1 more source

CD123-Targeted Therapy Shows Long-Term Benefit for BPDCN Patients

Oncology Times, 2022
openaire   +1 more source

Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond

Current Hematologic Malignancy Reports, 2017
Naveen Pemmaraju
exaly  

Pre-Clinical Studies of Anti-CD123 CAR-T Cells for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Blood, 2016
Monica L Guzman, Naveen Pemmaraju
exaly  

Clinical Hold Lifted on UCART123 Trials for AML/BPDCN

Oncology Times, 2017
openaire   +1 more source

Primary Cutaneous Presentation of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

European Journal of Cancer
Ch. Oikonomidi, Anthi Bouchla, Kyriaki Lampadaki, Leonidas Marinos, Evangelia Papadavid, Vasiliki Pappa   +5 more
openaire   +1 more source

Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations

Annals of Hematology
Axel Künstner, Susanne Ghandili, Philipp Ströbel   +2 more
exaly  

Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCNs)

openaire   +1 more source

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) presenting as bruise-like plaques

Journal of the American Academy of Dermatology, 2018
openaire   +1 more source

Managing BPDCN in the context of severe hyperbilirubinemia: a case study

Leukemia & Lymphoma
Jennifer Croden, Naveen Pemmaraju, Kelley Fliehler, Arsemen Brown, Wei Wang, Hagop Kantarjian, Francisco Vega, Tapan Kadia   +7 more
openaire   +1 more source